Soma S Nag

Summary

Affiliation: Merck Research Laboratories
Country: USA

Publications

  1. ncbi Estimating cholesterol treatment rates among individuals with multiple risk factors and without coronary heart disease
    Soma S Nag
    Outcomes Research and Management, Merck and Co, Inc, West Point, Pennsylvania, USA
    Am J Cardiol 95:862-4. 2005
  2. ncbi LDL-C goal attainment among patients newly diagnosed with coronary heart disease or diabetes in a commercial HMO
    Soma S Nag
    Merck and Co, Inc, 770 Broad Street, West Point, PA, USA
    J Manag Care Pharm 13:652-63. 2007
  3. ncbi Reassessment of cardiovascular risk in diabetes
    Jonathan R Jaffe
    Merck and Co, Inc, Sumneytown Pike, West Point, Pennsylvania 19486, USA
    Curr Opin Lipidol 17:644-52. 2006
  4. ncbi Trends in lipid management among patients with diabetes
    Kaan Tunceli
    Center for Health Services Research, Henry Ford Health System, Detroit, Michigan 48202, USA
    Endocr Pract 12:380-7. 2006

Detail Information

Publications4

  1. ncbi Estimating cholesterol treatment rates among individuals with multiple risk factors and without coronary heart disease
    Soma S Nag
    Outcomes Research and Management, Merck and Co, Inc, West Point, Pennsylvania, USA
    Am J Cardiol 95:862-4. 2005
    ..The overall lipid-lowering therapy treatment rate was 38% and the estimated lipid treatment gap (percent needing treatment who were not receiving it) was 62%...
  2. ncbi LDL-C goal attainment among patients newly diagnosed with coronary heart disease or diabetes in a commercial HMO
    Soma S Nag
    Merck and Co, Inc, 770 Broad Street, West Point, PA, USA
    J Manag Care Pharm 13:652-63. 2007
    ..Patients with coronary heart disease or diabetes are at high risk of coronary events and are particularly important target groups for monitoring and dose adjustment of lipid-modifying drug therapy...
  3. ncbi Reassessment of cardiovascular risk in diabetes
    Jonathan R Jaffe
    Merck and Co, Inc, Sumneytown Pike, West Point, Pennsylvania 19486, USA
    Curr Opin Lipidol 17:644-52. 2006
    ..To review recent trials and reassess cardiovascular risk in people with diabetes...
  4. ncbi Trends in lipid management among patients with diabetes
    Kaan Tunceli
    Center for Health Services Research, Henry Ford Health System, Detroit, Michigan 48202, USA
    Endocr Pract 12:380-7. 2006
    ..To examine trends in lipid management (cholesterol testing, treatment, and goal attainment) among patients with diabetes and to analyze the factors associated with initiation of lipid-lowering therapy...